Literature DB >> 12730694

Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease.

Cristina Tufarelli1, Jackie A Sloane Stanley, David Garrick, Jackie A Sharpe, Helena Ayyub, William G Wood, Douglas R Higgs.   

Abstract

Nearly all human genetic disorders result from a limited repertoire of mutations in an associated gene or its regulatory elements. We recently described an individual with an inherited form of anemia (alpha-thalassemia) who has a deletion that results in a truncated, widely expressed gene (LUC7L) becoming juxtaposed to a structurally normal alpha-globin gene (HBA2). Although it retains all of its local and remote cis-regulatory elements, expression of HBA2 is silenced and its CpG island becomes completely methylated early during development. Here we show that in the affected individual, in a transgenic model and in differentiating embryonic stem cells, transcription of antisense RNA mediates silencing and methylation of the associated CpG island. These findings identify a new mechanism underlying human genetic disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730694     DOI: 10.1038/ng1157

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  204 in total

1.  The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes.

Authors:  Sanjay Chandriani; Yiyang Xu; Don Ganem
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Differential subnuclear localization of RNA strands of opposite polarity derived from an autonomously replicating viroid.

Authors:  Yijun Qi; Biao Ding
Journal:  Plant Cell       Date:  2003-10-10       Impact factor: 11.277

3.  Lack of homologous sequence-specific DNA methylation in response to stable dsRNA expression in mouse oocytes.

Authors:  Petr Svoboda; Paula Stein; Witold Filipowicz; Richard M Schultz
Journal:  Nucleic Acids Res       Date:  2004-07-09       Impact factor: 16.971

4.  Detection of a novel sense-antisense RNA-hybrid structure by RACE experiments on endogenous troponin I antisense RNA.

Authors:  Holger Bartsch; Stefanie Voigtsberger; Gert Baumann; Ingo Morano; Hans Peter Luther
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

5.  Regulation of Antisense Transcription by NuA4 Histone Acetyltransferase and Other Chromatin Regulatory Factors.

Authors:  Bhawana Uprety; Amala Kaja; Jannatul Ferdoush; Rwik Sen; Sukesh R Bhaumik
Journal:  Mol Cell Biol       Date:  2016-01-11       Impact factor: 4.272

6.  Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.

Authors:  Henrietta Szutorisz; Claudia Canzonetta; Andrew Georgiou; Cheok-Man Chow; László Tora; Niall Dillon
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible.

Authors:  Hiromi Tagoh; Alexandra Schebesta; Pascal Lefevre; Nicola Wilson; David Hume; Meinrad Busslinger; Constanze Bonifer
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

Review 8.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Zinc-dependent regulation of the Adh1 antisense transcript in fission yeast.

Authors:  Kate M Ehrensberger; Carter Mason; Mark E Corkins; Cole Anderson; Natalie Dutrow; Bradley R Cairns; Brian Dalley; Brett Milash; Amanda J Bird
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

10.  Hybrid vigor and transgenerational epigenetic effects on early mouse embryo phenotype.

Authors:  Zhiming Han; Namdori R Mtango; Bela G Patel; Carmen Sapienza; Keith E Latham
Journal:  Biol Reprod       Date:  2008-06-18       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.